|
1
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Pell VR, Chouchani ET, Frezza C, Murphy MP
and Krieg T: Succinate metabolism: A new therapeutic target for
myocardial reperfusion injury. Cardiovasc Res. 111:134–141.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Whayne TF Jr: Ischemic heart disease and
the Mediterranean diet. Curr Cardiol Rep. 16(491)2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Nordlie MA, Wold LE, Simkhovich BZ, Sesti
C and Kloner RA: Molecular aspects of ischemic heart disease:
Ischemia/reperfusion-induced genetic changes and potential
applications of gene and RNA interference therapy. J Cardiovasc
Pharmacol Ther. 11:17–30. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Feyzizadeh S and Badalzadeh R: Application
of ischemic postconditioning's algorithms in tissues protection:
Response to methodological gaps in preclinical and clinical
studies. J Cell Mol Med. 21:2257–2267. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Orchard TJ and Costacou T: When are type 1
diabetic patients at risk for cardiovascular disease? Curr Diab
Rep. 10:48–54. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gharravi AM, Jafar A, Ebrahimi M, Mahmodi
A, Pourhashemi E, Haseli N, Talaie N and Hajiasgarli P: Current
status of stem cell therapy, scaffolds for the treatment of
diabetes mellitus. Diabetes Metab Syndr. 12:1133–1139.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Whittington HJ, Babu GG, Mocanu MM, Yellon
DM and Hausenloy DJ: The diabetic heart: Too sweet for its own
good? Cardiol Res Pract. 2012(845698)2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li N, Yang YG and Chen MH: Comparing the
adverse clinical outcomes in patients with non-insulin treated type
2 diabetes mellitus and patients without type 2 diabetes mellitus
following percutaneous coronary intervention: A systematic review
and meta-analysis. BMC Cardiovasc Disord. 16(238)2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lejay A, Fang F, John R, Van JA, Barr M,
Thaveau F, Chakfe N, Geny B and Scholey JW: Ischemia reperfusion
injury, ischemic conditioning and diabetes mellitus. J Mol Cell
Cardiol. 91:11–22. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Jha JC, Ho F, Dan C and Jandeleit-Dahm K:
A causal link between oxidative stress and inflammation in
cardiovascular and renal complications of diabetes. Clin Sci
(Lond). 132:1811–1836. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Salehi B, Fokou PV, Sharifi-Rad M, Zucca
P, Pezzani R, Martins N and Sharifi-Rad J: The therapeutic
potential of naringenin: A review of clinical trials.
Pharmaceuticals (Basel). 12(E11)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Testai L, Da Pozzo E, Piano I, Pistelli L,
Gargini C, Breschi MC, Braca A, Martini C, Martelli A and Calderone
V: The citrus flavanone naringenin produces cardioprotective
effects in hearts from 1 year old rat, through activation of mitoBK
channels. Front Pharmacol. 8(71)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Han X, Pan J, Ren D, Cheng Y, Fan P and
Lou H: Naringenin-7-O-glucoside protects against
doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of
endogenous antioxidant enzymes. Food Chem Toxicol. 46:3140–3146.
2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Han X, Ren D, Fan P, Shen T and Lou H:
Protective effects of naringenin-7-O-glucoside on
doxorubicin-induced apoptosis in H9C2 cells. Eur J Pharmacol.
581:47–53. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Han XZ, Gao S, Cheng YN, Sun YZ, Liu W,
Tang LL and Ren DM: Protective effect of naringenin-7-O-glucoside
against oxidative stress induced by doxorubicin in H9c2
cardiomyocytes. Biosci Trends. 6:19–25. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Arafa HM, Abd-Ellah MF and Hafez HF:
Abatement by naringenin of doxorubicin-induced cardiac toxicity in
rats. J Egypt Natl Canc Inst. 17:291–300. 2005.PubMed/NCBI
|
|
18
|
Chtourou Y, Slima AB, Makni M, Gdoura R
and Fetoui H: Naringenin protects cardiac
hypercholesterolemia-induced oxidative stress and subsequent
necroptosis in rats. Pharmacol Rep. 67:1090–1097. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yu LM, Dong X, Zhang J, Li Z, Xue XD, Wu
HJ, Yang ZL, Yang Y and Wang HS: Naringenin attenuates myocardial
ischemia-reperfusion injury via cGMP-PKGIα signaling and in vivo
and in vitro studies. Oxid Med Cell Longev.
2019(7670854)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yu LM, Dong X, Xue XD, Zhang J, Li Z, Wu
HJ, Yang ZL, Yang Y and Wang HS: Naringenin improves mitochondrial
function and reduces cardiac damage following ischemia-reperfusion
injury: The role of the AMPK-SIRT3 signaling pathway. Food Funct.
10:2752–2765. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
You Q, Wu Z, Wu B, Liu C, Huang R, Yang L,
Guo R, Wu K and Chen J: Naringin protects cardiomyocytes against
hyperglycemia-induced injuries in vitro and in vivo. J Endocrinol.
230:197–214. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yao H and Han X and Han X: The
cardioprotection of the insulin-mediated PI3K/Akt/mTOR signaling
pathway. Am J Cardiovasc Drugs. 14:433–442. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Viard P, Butcher AJ, Halet G, Davies A,
Nürnberg B, Heblich F and Dolphin AC: PI3K promotes
voltage-dependent calcium channel trafficking to the plasma
membrane. Nat Neurosci. 7:939–946. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Shen D, Chen R, Zhang L, Rao Z, Ruan Y, Li
L, Chu M and Zhang Y: Sulodexide attenuates endoplasmic reticulum
stress induced by myocardial ischaemia/reperfusion by activating
the PI3K/Akt pathway. J Cell Mol Med. 23:5063–5075. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang BF, Jiang H, Chen J, Guo X, Li Y, Hu
Q and Yang S: Nobiletin ameliorates myocardial ischemia and
reperfusion injury by attenuating endoplasmic reticulum
stress-associated apoptosis through regulation of the PI3K/AKT
signal pathway. Int Immunopharmacol. 73:98–107. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Deng T, Wang Y, Wang C and Yan H: FABP4
silencing ameliorates hypoxia reoxygenation injury through the
attenuation of endoplasmic reticulum stress-mediated apoptosis by
activating PI3K/Akt pathway. Life Sci. 224:149–156. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jiang C, Ji N, Luo G, Ni S, Zong J, Chen
Z, Bao D, Gong X and Fu T: The effects and mechanism of miR-92a and
miR-126 on myocardial apoptosis in mouse ischemia-reperfusion
model. Cell Biochem Biophys. 70:1901–1906. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang W, Zheng Y, Wang M, Yan M, Jiang J
and Li Z: Exosomes derived miR-126 attenuates oxidative stress and
apoptosis from ischemia and reperfusion injury by targeting ERRFI1.
Gene. 690:75–80. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Moghaddam AS, Afshari JT, Esmaeili SA,
Saburi E, Joneidi Z and Momtazi-Borojeni AA: Cardioprotective
microRNAs: Lessons from stem cell-derived exosomal microRNAs to
treat cardiovascular disease. Atherosclerosis. 285:1–9.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pishavar E and Behravan J: miR-126 as a
Therapeutic Agent for Diabetes Mellitus. Curr Pharm Des.
23:3309–3314. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Naderi R, Mohaddes G, Mohammadi M,
Alihemmati A, Khamaneh A, Ghyasi R and Ghaznavi R: The effect of
garlic and voluntary exercise on cardiac angiogenesis in diabetes:
The role of miR-126 and miR-210. Arq Bras Cardiol. 112:154–162.
2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Bhutada P, Mundhada Y, Bansod K, Bhutada
C, Tawari S, Dixit P and Mundhada D: Ameliorative effect of
quercetin on memory dysfunction in streptozotocin-induced diabetic
rats. Neurobiol Learn Mem. 94:293–302. 2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Bayrami G, Alihemmati A, Karimi P, Javadi
A, Keyhanmanesh R, Mohammadi M, Zadi-Heydarabad M and Badalzadeh R:
Combination of vildagliptin and ischemic postconditioning in
diabetic hearts as a working strategy to reduce myocardial
reperfusion injury by restoring mitochondrial function and
autophagic activity. Adv Pharm Bull. 8:319–329. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Xiao C, Xia ML, Wang J, Zhou XR, Lou YY,
Tang LH, Zhang FJ, Yang JT and Qian LB: Luteolin attenuates cardiac
ischemia/reperfusion injury in diabetic rats by modulating Nrf2
antioxidative function. Oxid Med Cell Longev.
2019(2719252)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yu L, Liang H, Dong X, Zhao G, Jin Z, Zhai
M, Yang Y, Chen W, Liu J, Yi W, et al: Reduced silent information
regulator 1 signaling exacerbates myocardial ischemia-reperfusion
injury in type 2 diabetic rats and the protective effect of
melatonin. J Pineal Res. 59:376–390. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yang JT, Qian LB, Zhang FJ, Wang J, Ai H,
Tang LH and Wang HP: Cardioprotective effects of luteolin on
ischemia/reperfusion injury in diabetic rats are modulated by eNOS
and the mitochondrial permeability transition pathway. J Cardiovasc
Pharmacol. 65:349–356. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yang Y, Duan W, Jin Z, Yi W, Yan J, Zhang
S, Wang N, Liang Z, Li Y, Chen W, et al: JAK2/STAT3 activation by
melatonin attenuates the mitochondrial oxidative damage induced by
myocardial ischemia/reperfusion injury. J Pineal Res. 55:275–286.
2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-ΔΔC(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Meng LM, Ma HJ, Guo H, Kong QQ and Zhang
Y: The cardioprotective effect of naringenin against
ischemia-reperfusion injury through activation of ATP-sensitive
potassium channel in rat. Can J Physiol Pharmacol. 94:973–978.
2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kumar A, Kaur H, Devi P and Mohan V: Role
of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and
Meniere-like syndrome. Pharmacol Ther. 124:259–268. 2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Du L, Zhang H, Zhao H, Cheng X, Qin J,
Teng T, Yang Q and Xu Z: The critical role of the zinc transporter
Zip2 (SLC39A2) in ischemia/reperfusion injury in mouse hearts. J
Mol Cell Cardiol. 132:136–145. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yang M, Kong DY and Chen JC: Inhibition of
miR-148b ameliorates myocardial ischemia/reperfusion injury via
regulation of Wnt/β-catenin signaling pathway. J Cell Physiol.
234:17757–17766. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Mamamtavrishvili ND, Sharashidze NS,
Abashidze RI and Kvirkveliia AA: Metabolic issues of ischemia
induced myocardial dysfunction. Georgian Med News. 195:40–43.
2011.PubMed/NCBI(In Russian).
|
|
44
|
Sinning C, Westermann D and Clemmensen P:
Oxidative stress in ischemia and reperfusion: Current concepts,
novel ideas and future perspectives. Biomarkers Med.
11:11031–11040. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Taysi S, Tascan AS, Ugur MG and Demir M:
Radicals, oxidative/nitrosative stress and preeclampsia. Mini Rev
Med Chem. 19:178–193. 2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Kołodziej U, Maciejczyk M, Miąsko A,
Matczuk J, Knaś M, Żukowski P, Żendzian-Piotrowska M, Borys J and
Zalewska A: Oxidative modification in the salivary glands of high
fat-diet induced insulin resistant rats. Front Physiol.
8(20)2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhao H, Zhao M, Wang Y, Li F and Zhang Z:
Glycyrrhizic acid prevents sepsis-induced acute lung injury and
mortality in rats. J Histochem Cytochem. 64:125–137.
2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kara S, Gencer B, Karaca T, Tufan HA,
Arikan S, Ersan I, Karaboga I and Hanci V: Protective effect of
hesperetin and naringenin against apoptosis in
ischemia/reperfusion-induced retinal injury in rats.
ScientificWorldJournal. 2014(797824)2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Wojnar W, Zych M and Kaczmarczyk-Sedlak I:
Antioxidative effect of flavonoid naringenin in the lenses of type
1 diabetic rats. Biomed Pharmacother. 108:974–984. 2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Al-Dosari DI, Ahmed MM, Al-Rejaie SS,
Alhomida AS and Ola MS: Flavonoid naringenin attenuates oxidative
stress, apoptosis and improves neurotrophic effects in the diabetic
rat retina. Nutrients. 9(E1161)2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Roy S, Ahmed F, Banerjee S and Saha U:
Naringenin ameliorates streptozotocin-induced diabetic rat renal
impairment by downregulation of TGF-β1 and IL-1 via modulation of
oxidative stress correlates with decreased apoptotic events. Pharm
Biol. 54:1616–1627. 2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Zhang J, Qiu H, Huang J, Ding S, Huang B,
Wu Q and Jiang Q: Naringenin exhibits the protective effect on
cardiac hypertrophy via EETs-PPARs activation in
streptozocin-induced diabetic mice. Biochem Biophys Res Commun.
502:55–61. 2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Nishina A, Sato D, Yamamoto J,
Kobayashi-Hattori K, Hirai Y and Kimura H: Antidiabetic-like
effects of naringenin-7-O-glucoside from edible chrysanthemum
‘Kotobuki’ and naringenin by activation of the PI3K/Akt pathway and
PPARγ. Chem Biodivers. 16(e1800434)2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Cheng X, Hu J, Wang Y, Ye H, Li X, Gao Q
and Li Z: Effects of dexmedetomidine postconditioning on myocardial
ischemia/reperfusion injury in diabetic rats: Role of the
PI3K/Akt-dependent signaling pathway. J Diabetes Res.
2018(3071959)2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Mahajan UB, Patil PD, Chandrayan G, Patil
CR, Agrawal YO, Ojha S and Goyal SN: Eplerenone pretreatment
protects the myocardium against ischaemia/reperfusion injury
through the phosphatidylinositol 3-kinase/Akt-dependent pathway in
diabetic rats. Mol Cell Biochem. 446:91–103. 2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Gai HY, Wu C, Zhang Y and Wang D: Long
non-coding RNA CHRF modulates the progression of cerebral
ischemia/reperfusion injury via miR-126/SOX6 signaling pathway.
Biochem Biophys Res Commun. 514:550–557. 2019.PubMed/NCBI View Article : Google Scholar
|
